
Ziprax CL 200mg/125mg Tablet
Marketer
Cipla Ltd
Salt Composition
Cefixime (200mg) + Clavulanic Acid (125mg)
Overview Ziprax CL 200mg/125mg Tablet
Combiflox CL, a 200mg/125mg tablet, combats bacterial infections by inhibiting microbial growth and propagation. This prescription medication should be taken precisely as directed. While food is not mandatory, consistent timing maximizes effectiveness. Exceeding the prescribed dosage is dangerous. Missed doses should be taken immediately upon recollection. Complete the full course of treatment, even with symptom improvement, to prevent treatment failure. Side effects, such as nausea, vomiting, diarrhea, and indigestion, are possible. Severe side effects necessitate immediate medical consultation. Allergic reactions (rashes, itching, swelling, breathing difficulty) require emergency care. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to increased drowsiness. While driving ability is typically unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration promote faster recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Ziprax CL 200mg/125mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Ziprax CL 200mg/125mg Tablet
Combating Bacterial Infections
Major Benefits of Ziprax CL 200mg/125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg/125mg Ziprax CL Tablet whole; do not chew, crush, or divide it. While you may consume it with or without food, consistent timing is recommended.
Common Side effects of Ziprax CL 200mg/125mg Tablet:
- Nausea
- Diarrhea
- Stomach pain
- Indigestion
- Flatulence
How to use Ziprax CL 200mg/125mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 200mg/125mg Ziprax CL tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
How Ziprax CL 200mg/125mg Tablet works:
Each Ziprax CL 200mg/125mg tablet unites Cefixime, an antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Cefixime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Clavulanic Acid counteracts bacterial resistance mechanisms, thereby boosting Cefixime's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ziprax CL 200mg/125mg tablets requires careful consideration. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ziprax CL 200mg/125mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Ziprax CL 200mg/125mg Tablet is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Ziprax CL 200mg/125mg Tablets, including potential allergic reactions, dizziness, or seizures.
KidneyCAUTION
Exercise caution when administering Ziprax CL 200mg/125mg tablets to individuals with impaired renal function. Dosage modification for Ziprax CL 200mg/125mg tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Ziprax CL 200mg/125mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Ziprax CL 200mg/125mg Tablet :
Should you forget a Ziprax CL 200mg/125mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ziprax CL 200mg/125mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
